InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Karabelas Argeris N. Director active across 2 companies, notably Bausch Health Companies Inc.. In total, 11 disclosures have been published. History available since 30 April 2021. The latest transaction was disclosed on 30 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Karabelas Argeris N
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
7,768 股0Common StockSEC:0001562180-25-004348:0
10,000 股@ US$3.7612.7% 占其流量Common StockSEC:0001562180-24-007144:0
10,000 股@ US$3.7612.7% 占其流量Common StockSEC:0001562180-24-006657:0
10,000 股@ US$3.7613.0% 占其流量Common StockSEC:0001562180-24-006015:0
11,000 股@ US$12.7448.4% 占其流量Common StockSEC:0001562180-24-005875:0
10,000 股@ US$3.7613.1% 占其流量Common StockSEC:0001562180-24-005566:0
4,790 股0Common StockSEC:0001562180-24-004654:0
3,486 股0Common StockSEC:0001562180-23-004890:0
34,387 股0Common Shares, No Par ValueSEC:0001127602-22-018201:0
3,010 股0Common StockSEC:0001562180-22-004878:0
7,645 股0Common Shares, No Par ValueSEC:0001127602-21-014909:0
11 条申报中的 11 条
About Karabelas Argeris N
KARABELAS ARGERIS N is a declarant and a director of REGENXBIO Inc. and Bausch Health Companies Inc. The declarant has 11 filings in total, and the 11 sampled filings run from 2021-05-03 to 2024-10-02, with transaction nature shown as Attribution and buy and sell amounts of 0 in this recent sample.
